FDA advisers are currently undertaking a careful evaluation of Sarepta’s Duchenne gene therapy, a groundbreaking treatment that holds immense potential…
benefit-risk profile
1 post
FDA advisers are currently undertaking a careful evaluation of Sarepta’s Duchenne gene therapy, a groundbreaking treatment that holds immense potential…